Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells

Virologica Sinica

Volumn 27, Issue 4, 2012, Pages 221-227

  Jin, Jun ^a   Han, Mingming ^a   Xu, Lin ^a   An, Dong ^a   Kong, Wei ^a   Jiang, Chunlai ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Coxsackievirus A16 (CVA16); Hand foot and mouth disease (HFMD); QRT PCR; Viral kinetics; Western blotting

Indexed keywords

RNA; VIRUS ANTIGEN;

ARTICLE; CELL VIABILITY; COXSACKIE VIRUS A; COXSACKIE VIRUS A16; CYTOPATHOGENIC EFFECT; HOST CELL; HUMAN; INFECTION CONTROL; NONHUMAN; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; RNA REPLICATION; SECONDARY INFECTION; VIRION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION;

CELL LINE, TUMOR; CHINA; CYTOPATHOGENIC EFFECT, VIRAL; ENTEROVIRUS; HUMANS; TIME FACTORS; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS CULTIVATION; VIRUS INTERNALIZATION; VIRUS RELEASE; VIRUS REPLICATION;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS 71;

EID: 84869114184     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-012-3245-x     Document Type: Article

References (35)

1. Ang L W, Koh B K, Chan K P, et al. 2009. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore, 38(2):106-112.
2. Baccam P, Beauchemin C, Macken C A, et al. 2006. Kinetics of influenza A virus infection in humans. J Virol, 80(15):7590-7599.
3. Cardosa M J, Perera D, Brown B A, et al. 2003. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: Comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis, 9(4):461-468.
4. Chun T W, Carruth L, Finzi D, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature, 387(6629):183-188.
5. Cromeans T, Fields H A, Sobsey M D. 1989. Replication kinetics and cytopathic effect of hepatitis A virus. J Gen Virol, 70 (Pt 8):2051-2062.
6. Egger D, Bienz K. 2005. Intracellular location and translocation of silent and active poliovirus replication complexes. J Gen Virol, 86(Pt 3):707-718.
7. Garcia P M, Kalish L A, Pitt J, et al. 1999. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med, 341(6):394-402.
8. Hadinoto V, Shapiro M, Sun C C, et al. 2009. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog, 5(7):e1000496.
9. Hollingsworth T D, Laeyendecker O, Shirreff G, et al. HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda. PLoS Pathog, 6 (5):e1000876.
10. Hosoya M, Kawasaki Y, Sato M, et al. 2007. Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003. J Clin Microbiol, 45 (1):112-120.
11. Jabs D A, Gilpin A M, Min Y I, et al. 2002. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS, 16 (6):877-887.
12. Kung Y H, Huang S W, Kuo P H, et al. Introduction of a strong temperature-sensitive phenotype into enterovirus 71 by altering an amino acid of virus 3D polymerase. Virology, 396 (1):1-9.
13. Lin K H, Hwang K P, Ke G M, et al. 2006. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol, 78 (2):254-262.
14. Lu J, He M L, Wang L, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res, 71 (1):225-233.
15. Lu J, He Y Q, Yi L N, et al. Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol, 17 (36):4135-4142.
16. Lyles R H, Munoz A, Yamashita T E, et al. 2000. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis, 181 (3):872-880.
17. Ma Y, Yu J, Chan H L, et al. 2009. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics, 8(11):2582-2594.
18. McMinn P C. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev, 26(1):91-107.
19. Mellors J W, Munoz A, Giorgi J V, et al. 1997. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med, 126(12):946-954.
20. Muir P, Kammerer U, Korn K, et al. 1998. Molecular typing of enteroviruses: Current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev, 11(1):202-227.
21. Neumann A U, Lam N P, Dahari H, et al. 1998. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science, 282(5386):103-107.
22. Nijhuis M, van Maarseveen N, Schuurman R, et al. 2002. Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR. J Clin Microbiol, 40 (10):3666-3670.
23. Nishimura Y, Shimojima M, Tano Y, et al. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med, 15 (7):794-797.
24. Perelson A S, Neumann A U, Markowitz M, et al. 1996. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science, 271 (5255):1582-1586.
25. Podin Y, Gias E L, Ong F, et al. 2006. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health, 6:180.
26. Rabenau H F, Richter M, Doerr H W. Hand, foot and mouth disease: Seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol, 199 (1):45-51.
27. Ribeiro R M, Lo A, Perelson A S. 2002. Dynamics of hepatitis B virus infection. Microbes Infect, 4 (8):829-835.
28. Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis, (11):778-790.
29. Yamayoshi S, Yamashita Y, Li J, et al. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med, 15 (7):798-801.
30. Yi L, He Y, Chen Y, et al. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ther, 16 (1):51-58.
31. Thomas D L, Villano S A, Riester K A, et al. 1998. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis, 177 (6):1480-1488.
32. Yip C C, Lau S K, Zhou B, et al. Emergence of enterovirus 71 "double-recombinant" strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch Virol, 155 (9):1413-1424.
33. Zhang H M, Li C R, Liu Y J, et al. 2009. To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008. Chin J Exp Clin Virol, 23 (5):334-336.(in Chinese)
34. Zhang Y, Zhu Z, Yang W, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J, 7:94.
35. Zoll J, Heus H A, van Kuppeveld F J, et al. 2009. The structure-function relationship of the enterovirus 3'-UTR. Virus Res, 139 (2):209-216.